Upexi, Inc. (UPXI) Stock

Upexi, Inc. (UPXI) is a Financials stock trading at $0.79 (as of 2026-06-30), with a market capitalization of $55.34M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Upexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.

Understand Upexi, Inc.: how it makes money

Upexi makes and sells branded products in health, wellness, pet, and beauty markets, and it also has crypto staking-related activity, with this quarter showing 0.0B consumer brand and digital asset revenue alongside 0.01B of staking revenue.

The profit model appears to be driven by crypto token staking activity, because the reported operating metrics emphasize Solana tokens staked and the quarter includes non-zero staking revenue, while consumer brands and digital asset revenue are shown as 0.0B in the provided data.

Revenue by segment (latest quarter)
Vitamedica$0.0B
LuckyTail$0.0B
TitanTiles$0.0B
DigitalAssets$0.0B
ConsumerBrands$0.0B

Business quality (Mixed): Segment and operating metric visibility is limited in the provided data, with most segment revenue lines at 0.0B while operating results are still deeply negative.

Valuation: At 2× earnings, UPXI trades 88% below the Banking average (13×). Note: one-time items can distort reported P/E.

Bull case

  • High reported gross margin (95.5%): If revenue scales, the cost structure implied by gross margin could support profitability.
  • High staking participation (Percent of Solana Tokens Staked = 95.0%): A large share of Solana tokens appears positioned for staking, which aligns with the existence of staking revenue (0.01B).

Bear case

  • Extremely negative operating margin (-2343.3%): The business is operating at a substantial loss relative to revenue in the latest quarter.
  • Near-zero reported revenue lines for multiple areas: In the provided data, Vitamedica, Lucky Tail, Titan Tiles, digital assets, and consumer brands revenue are shown as 0.0B, which limits diversification of revenue sources.
Valuation — source: SEC EDGAR (first-party)
Price$0.79
Market Cap$55.34M
Price / Sales2.21
FCF Yield-79.3%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$15.81M
Net Margin-86.5%
Revenue Growth (YoY)44.2%
EPS Growth (YoY)-41.8%
FCF Growth (YoY)298.6%
Financial Health — source: SEC EDGAR
Altman Z-Score0.17 (distress)
Piotroski F-Score4/9 (moderate)
Valuation vs Sector & Industry
Sector P/E (Financials)15.1
Industry P/E (Banking)13.0
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderPantera Capital Partners LP ($3.97M)
Institutional Holders Tracked10
Company
SectorFinancials
IndustryBanking
CEOAllan J. Marshall
Employees64
CountryUS
IPO Date2021-06-24

Related Companies (Business model: Crypto Exchange / Custody / Staking; 8 closest by market cap; US-domiciled)

  • SUI Group Holdings Limited (SUIG)
  • BTCS Inc. (BTCS)
  • Exodus Movement, Inc. (EXOD)
  • Brag House Holdings, Inc. (TBH)
  • Yorkville Acquisition Corp. (MCGA)
  • American Bitcoin Corp (ABTC)
  • The Marygold Companies, Inc. (MGLD)
  • Big Digital Energy, Inc. (BGDE)
UPXI earnings history · UPXI institutional & insider holders · UPXI KPIs & operating metrics · UPXI financials · UPXI investor presentations & press releases · UPXI SEC filings · UPXI peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-30.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.